https://scholars.lib.ntu.edu.tw/handle/123456789/496311
標題: | Evidence for thiazolidinedione, insulin sensitizers in the treatment of type 2 diabetes mellitus | 作者: | CHIH-YUAN WANG TIEN-CHUN CHANG |
公開日期: | 2007 | 卷: | 18 | 期: | 1 | 起(迄)頁: | 11-19 | 來源出版物: | Journal of Internal Medicine of Taiwan | 摘要: | In Taiwan, the epidemiological research had showed increasing prevalence of hyperglycemia in general population, including adolescent. Previous studies showed that life style intervention could play a pivotal role to prevent ongoing diabetes mellitus in together with certain oral medication. Amongst, insulin sensitizers have different pharmacological mechanism from conventional oral hypoglycemic agents. Insulin sensitizers can not only improve blood glucose control, but decrease insulin resistance via activation peroxisome proliferator-activated receptors, PPARs. This review will focus on recent evidence-based data for insulin sensitizers to elucidate several important issues, including their side effects, pharmacological mechanism, pharmacokinetics, and pharmacoeconomics. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947711743&partnerID=40&md5=c881db7a37933cab137ca98083909001 https://scholars.lib.ntu.edu.tw/handle/123456789/496311 |
ISSN: | 1016-7390 | SDG/關鍵字: | 2,4 thiazolidinedione derivative; adiponectin; C reactive protein; insulin sensitizing agent; metformin; peroxisome proliferator activated receptor; pioglitazone; rosiglitazone; sulfonylurea; troglitazone; clinical trial; drug metabolism; evidence based medicine; glucose blood level; human; insulin sensitivity; non insulin dependent diabetes mellitus; nonalcoholic fatty liver; review; Taiwan; unspecified side effect |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。